61
14. Kami K, Doi R, Koizumi M, Toyoda E, Tomohiko M, Daisuke I.Survivin expression is
a prognostic marker in pancreatic cancer patients.Surgery 2004 ;136(2) :443-8.
15. Rodel F, Hoffmann J, Distel L, Herrmann M, Noisternig T,Papadopoulos T.Survivin as
a radioresistance factor , and prognostic and therapeutic target for radiotherapy in rectal
cancer.Cancer Research 2005 ;65( 11) : 4881-7.
16. Knutsen A, Gunnar A, Sun X.Survivin expression is a independent prognostic factor in
rectal cancer patients with and without preoperative radiotherapy. International Journal
Oncology Biology Physics 2004 ; 60 (1) : 149-55
17. Rödel F, Hoffmann J, Grabenbauer G, Papadopoulos T ,WeiB C,Günther K.High
surviving expression is associated with reduced apoptosis in rectal cancer and may
predict disease- free survival after preoperative radiochemotherapy and surgical
resection.Strahlenther Onkologie 2002;178:426-35
18. Oshita F, Ito H, Ikehara M, Ohgane N, Hamanaka N, Nakayama H.Prognostic impact of
survivin, cyclinD1, integrin B1, and VEGF in patients with small adenocarcinoma of
stage I lung cancer.American Journal of Clinical Oncology 2004;27:425-2.
19. Lu B, Gonzalez A, Massion P, Shyr Y, Shaktour B, Carbone D.Nuclear survivin as a
biomarker for non-small-cell lung cancer.British Journal of Cancer 2004 ;91: 537-40.
20. Vischioni B, Valk P, Span S, Kruyt A,Rodriguez J, Giaccone G.Nuclear localization of
survivin is a positive prognostic factor for survival in advanced non-small-cell lung
cancer.Annals of Oncology 2004;15: 1654-60.
21. Monzó M, Rosell R, Felip E, Astudillo J, Sánchez J, Maestre J.A novel antiapoptotic
gene: re-expression of survivin messenger RNA as a prognostic marker in non-small-
cell lung cancers.Journal of Clinical Oncology 1999 ;17 (7):2100-04.
22. Yagihashi A, Asanuma K, Kobayashi D, Tsuji N, Shijubo Y, Abe S.Detection of
autoantibodies to livin and survivin in sera from lung cancer patients.Lung Cancer 2005
; 48 :217- 221.
23. Ikehara M, Oshita F, Kameda Y, Ito H, Ohgane N, Suzuki R.Expression of survivin
correlated with vessel invasion is a marker of poor prognosis in small adenocarcinoma
of the lung.Oncology Reports 2002; 9 : 835-38.
24. Hofmann H, Simm A, Hammer A,Silber R, Bartling B.Expression of inhibitors of
apoptosis ( IAP) proteins in non-small-cell human lung cancer.Journal of Cancer
Research Clinical Oncology 2002 ; 128 :554-60.
25. Park H, Lee E, Lee S.Expression of survivin , a novel inhibitor of apoptosis , in
superficial transitional cell carcinoma of the bladder.Urologic Oncology: Seminars and
Original Investigations 2004 ; 22:265-74.
26. Aparicio T , Boigea V, Sabourinb J, Crennc P , Ducreuxa M, Le Cesnea A.Prognostic
factors after surgery of primary resectable gastrointestinal stromal tumours.European
Journal of Surgical Oncology 2004; 30:1098–1103.